The American College of Cardiology released a 2026 scientific statement on antiplatelet therapy for atherosclerotic cardiovascular disease.

Peter Attia warns that simplicity is crushing nuance in science. I agree—so I took a closer look at his own argument on LDL, ...

Both non-HDL-C and apolipoprotein B levels independently predict ASCVD risk in patients not receiving statins.

Dr Slipczuk explores quality metrics, elaborating on ways to improve and align them with the latest cardiology treatment guidelines and payer considerations. Leandro N. Slipczuk, MD, PhD: We’re still ...

Early onset of menopause is an important risk factor for atherosclerotic cardiovascular disease (ASCVD), according to an analysis of women enrolled in numerous population-based studies. “To me, what ...

Approximately one in seven patients with atherosclerotic cardiovascular disease (ASCVD) experience some form of food insecurity, and the prevalence is even higher among the most-vulnerable subgroups, ...

Dr Slipczuk offers strategies for sharing information and guiding appropriate ASCVD treatment both within and outside closed health systems. Leandro N. Slipczuk, MD, PhD: To share information, it’s ...

Share on Pinterest A study found that a large number of patients do not receive recommended treatment for atherosclerotic cardiac disease (ASCVD). Denis Kirichkov/Stocksy In 2013, new guidelines were ...

A high percentage of people with type 2 diabetes also have atherosclerotic cardiovascular disease (ASCVD), but fewer than 1 in 20 get the triumvirate of evidence-based medications – drugs to lower ...

Ask the people in your life whose opinion you value to share the names of doctors they trust. Friends, relatives, neighbors, and co-workers are all great sources of information. Or maybe you already ...

The American College of Cardiology (ACC) has released an Expert Consensus Decision Pathway (ECDP) to provide guidance on treating and managing patients with atherosclerotic cardiovascular disease ...